3. Results and Discussion
Of the 143 HIV-infected subjects assessed for insulin sensitivity, 49 were insulin resistant
(KITT ≤ 1.620%/min), 47 had intermediate insulin sensitivity (1.620 < KITT ≤ 1.683) and 47 were
insulin sensitive (KITT > 1.683). Of the 49 subjects eligible for the trial, 3 did not meet inclusion
criteria while 13 refused to participate. Seventeen were therefore randomized to spirulina and 16 to the
soybean group. Two subjects were discontinued treatment in the spirulina group due to acute
intercurrent infection, 2 withdrew their consent while 2 loses to follow up were registered in the
spirulina group giving an overall follow up rate of 82% (Figure 1).